Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Su Kim

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Breast Cancer|July 12, 2014
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer RegistryJong-Han Yu, Jong Won Lee, Byung Ho Son, et al.
International Journal of Surgery (London, England)|November 24, 2023
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA studySoong June Bae, Hee Jeong Kim, Hyun-Ah Kim, et al.
Breast Cancer Research : BCR|November 6, 2024
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA SubstudyYoung Joo Lee, Woo Chul Noh, Sungchan Gwark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA TrialSoo Yeon Baek, Woo Chul Noh, Sei-Hyun Ahn, et al.
Breast Cancer Research and Treatment|March 3, 2012
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) StudyByung Ho Son, Sei Hyun Ahn, Sung-Won Kim, et al.
Journal of Breast Cancer|January 30, 2026
Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)Sung Gwe Ahn, Sung Hoon Sim, Taewoo Kang, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|June 25, 2008
The current status of endoscopic thyroidectomy in KoreaJa Seong Bae, Young Up Cho, Gi Young Sung, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III TrialHyun-Ah Kim, Jong Won Lee, Seok Jin Nam, et al.
Familial Cancer|November 8, 2012
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer studySang-Ah Han, Sung-Won Kim, Eunyoung Kang, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Breast Cancer|July 12, 2014
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer RegistryJong-Han Yu, Jong Won Lee, Byung Ho Son, et al.
International Journal of Surgery (London, England)|November 24, 2023
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA studySoong June Bae, Hee Jeong Kim, Hyun-Ah Kim, et al.
Breast Cancer Research : BCR|November 6, 2024
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA SubstudyYoung Joo Lee, Woo Chul Noh, Sungchan Gwark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA TrialSoo Yeon Baek, Woo Chul Noh, Sei-Hyun Ahn, et al.
Breast Cancer Research and Treatment|March 3, 2012
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) StudyByung Ho Son, Sei Hyun Ahn, Sung-Won Kim, et al.
Journal of Breast Cancer|January 30, 2026
Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)Sung Gwe Ahn, Sung Hoon Sim, Taewoo Kang, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|June 25, 2008
The current status of endoscopic thyroidectomy in KoreaJa Seong Bae, Young Up Cho, Gi Young Sung, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2019
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III TrialHyun-Ah Kim, Jong Won Lee, Seok Jin Nam, et al.
Familial Cancer|November 8, 2012
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer studySang-Ah Han, Sung-Won Kim, Eunyoung Kang, et al.
Pageof 5